Case Report: Identification of Two Rare Fusions, <i>PDK1-ALK</i> and <i>STRN-ALK</i>, That Coexist in a Lung Adenocarcinoma Patient and the Response to Alectinib. Here, STRN is linked to lung adenocarcinoma.